Abstract
A new HFAK which has completely different membrane material, Ethylene-Vinylalcahol copolymer membrane, from presently exsisting cellulosic was evaluated. In vitro examination evidenced that UFR was 3 times larger, CVB12 2 times larger, Cinulin 3 times larger, and Curea and Ccr at least comparable to that of conventional cellulosic HFAK.
In clinical assessment, UFR reduced to half of in vitro, but Curea, Ccr and Cu. a. were almost similar to in vitro.
